Bioresorbable Vascular Scaffolds Versus Drug-Eluting Stents for Diffuse Long Coronary Narrowings-Reference-Cited by-同舟云学术

Bioresorbable Vascular Scaffolds Versus Drug-Eluting Stents for Diffuse Long Coronary Narrowings

Published:2020-06 Issue:11 Volume:125 Page:1624-1630
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Seo Jongkwon,Ahn Jung-Min,Hong Sung-Jin,Kang Do-Yoon,Hong Soon Jun,Her Ae-Young,Kim Yong Hoon,Ahn Chul-Min,Kim Jung-Sun,Kim Byeong-Keuk,Ko Young-Guk,Choi Donghoon,Jang Yangsoo,Park Seung-Jung,Park Duk-Woo,Hong Myeong-Ki

Funder

Korea Health Technology Research & Development Project

Korea Health Industry Development Institute

Ministry of Health & Welfare, Republic of Korea

Bio & Medical Technology Development Program of the National Research Foundation

Asan Institute for Life Sciences

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Impact of ultra-long second-generation drug-eluting stent implantation;Honda;Catheter Cardiovasc Interv,2016

2. Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials);Lee;Am J Cardiol,2013

3. The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents

4. Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model

5. Bioresorbable vascular scaffold Korean expert panel report;Ahn;Korean Circ J,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases;Frontiers in Cell and Developmental Biology;2023-03-16

2. Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials;Open Heart;2022-10

3. Bioresorbable scaffolds vs. drug-eluting stents on short- and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2022-09-08

4. Lesion impacts on long-term outcomes in patients implanted with bioresorbable vascular scaffold;Journal of the Formosan Medical Association;2021-11

5. Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial;The International Journal of Cardiovascular Imaging;2021-08-21